Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | THRB | P10828 | 1/20 | 0.35 |
| ▸ | CA1 | P00915 | 1/20 | 0.30 |
| ▸ | CA2 | P00918 | 1/20 | 0.30 |
| ▸ | MMP1 | P03956 | 1/20 | 0.30 |
| ▸ | MMP2 | P08253 | 1/20 | 0.30 |
| ▸ | MMP9 | P14780 | 1/20 | 0.30 |
| ▸ | MMP8 | P22894 | 1/20 | 0.30 |
| ▸ | MMP13 | P45452 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8617976 | 1.00 | LMNA (0.35) | LMNATHRBCA1CA2MMP1 | |
| SCHEMBL63212 | 1.00 | LMNA (0.35) | LMNATHRBCA1CA2MMP1 | |
| SCHEMBL6906534 | 1.00 | LMNA (0.35) | LMNATHRBCA1CA2MMP1 | |
| SCHEMBL8614275 | 1.00 | LMNA (0.35) | LMNATHRBCA1CA2MMP1 | |
| SCHEMBL3133329 | 1.00 | LMNA (0.35) | LMNATHRBCA1CA2MMP1 | |
| SCHEMBL4228469 | 1.00 | LMNA (0.35) | LMNATHRBCA1CA2MMP1 | |
| SCHEMBL62965 | 1.00 | LMNA (0.35) | LMNATHRBCA1CA2MMP1 | |
| SCHEMBL4123177 | 1.00 | LMNA (0.35) | LMNATHRBCA1CA2MMP1 | |
| SCHEMBL17997086 | 1.00 | LMNA (0.35) | LMNATHRBCA1CA2MMP1 | |
| SCHEMBL4265800 | 1.00 | LMNA (0.35) | LMNATHRBCA1CA2MMP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1366 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4737638-A1 | PROTECTIVE FABRIC DISPLAYING WATER, OIL AND FUEL REPELLENCY | Safety Components International, Inc. (US) | 2026-05-06 | — | — | EP | claimed |
| EP-4676604-A1 | METHOD FOR REMOVING PFAS COMPRISED IN WASTE | SARP INDUSTRIES (FR) | 2026-01-14 | — | — | EP | claimed |
| US-20260008706-A1 | Utilization of Micro Hydroflocs for the Effective and Complete Removal of Long and Short Chain PFAS Molecules from Contaminated Water | StreamGo Water USA LLC (US) | 2026-01-08 | — | — | US | claimed |
| US-12454674-B2 | Method of encapsulating single cells utilizing an alternating current electrospray | UNIVERSITY OF NOTRE DAME DU LAC (US) | 2025-10-28 | — | — | US | claimed |
| EP-4628454-A1 | REMOVAL OF DIOXANE AND OTHER RECALCITRANT CONTAMINANTS FROM WATER USING NANOBUBBLES IN ADVANCED OXIDATION PROCESSES | StreamGo Water USA LLC (US) | 2025-10-08 | — | — | EP | claimed |
| US-20250304478-A1 | Removal of Dioxane and other Contaminants from Water using Oxygen Nanobubbles in Advanced Oxidation Processes | StreamGo Water USA LLC (US) | 2025-10-02 | — | — | US | claimed |
| WO-2025106778-A1 | POLYMERS FOR THE REMOVAL OF PFAS FROM AQUEOUS COMPOSITIONS, AND METHODS OF MAKING AND USING THE SAME | LUTUM TECHNOLOGY, LLC (US) | 2025-05-22 | — | — | WO | claimed |
| US-20250161911-A1 | POLYMERS FOR THE REMOVAL OF PFAS FROM AQUEOUS COMPOSITIONS, AND METHODS OF MAKING AND USING THE SAME | GULF COAST ENVIRONMENTAL SYSTEMS LLC (DBA CONIFER SYSTEMS) | 2025-05-22 | — | — | US | claimed |
| CN-119959197-A | Interaction analysis method of 8:2 fluorotelomer alcohol-target protein based on confocal fluorescence imaging | 华中农业大学 | 2025-05-09 | — | — | CN | claimed |
| US-20250037039-A1 | MOLECULAR DATA STORAGE USING COST-FREE MOLECULAR LIBRARIES | BROWN UNIVERSITY | 2025-01-30 | — | — | US | claimed |
| WO-2008076345-A1 | SURFACE MODIFYING MACROMOLECULES WITH HIGH DEGRADATION TEMPERATURES AND USES THEREOF | INTERFACE BIOLOGICS INC. (CA) | 2008-06-26 | — | — | WO | claimed |
| US-20080132643-A1 | Epoxidation of olefin/diene copolymers using hydrogen peroxide | EXXONMOBIL CHEMICAL PATENTS INC. | 2008-06-05 | — | — | US | claimed |
| US-6967236-B1 | Methods of processing and synthesizing electrically conductive polymers and precursors thereof to form electrically conductive polymers having high electrical conductivity | INTERNATIONAL BUSINESS MACHINES CORPORATION (US) | 2005-11-22 | — | — | US | claimed |
| US-20030194378-A1 | Novel aerosol formulation containing a polar fluorinated molecule | ASTRAZENECA AB (SE) | 2003-10-16 | — | — | US | claimed |
| EP-1303258-A1 | NOVEL AEROSOL FORMULATION CONTAINING A POLAR FLUORINATED MOLECULE | AstraZeneca AB (SE) | 2003-04-23 | — | — | EP | claimed |
| WO-2002003958-A1 | NOVEL AEROSOL FORMULATION CONTAINING A POLAR FLUORINATED MOLECULE | ASTRAZENECA AB (SE) | 2002-01-17 | — | — | WO | claimed |
| US-5874469-A | DRUG VEHICLE | ALCON LABORATORIES, INC. (US) | 1999-02-23 | — | — | US | claimed |
| WO-1996037540-A1 | FOAMABLE COMPOSITION CONTAINING UNSATURATED PERFLUOROCHEMICAL BLOWING AGENT | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1996-11-28 | — | — | WO | claimed |
| EP-0367583-B1 | FLUORINATED, ACRYLAMIDE-FUNCTIONAL MONOMERS | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1993-08-04 | — | — | EP | claimed |
| US-5210274-A | ETHYLENICALLY UNSATURATED, FLORINE-CONTAINING URETHANE DERIVATIVES AND PROCESS FOR THEIR PREPARATION | HOECHST AG (DE) | 1993-05-11 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260008706-A1 | Utilization of Micro Hydroflocs for the Effective and Complete Removal of Long and Short Chain PFAS Molecules from Contaminated Water | PFAS, FGB, F8 | LMNA 807/4885THRB 3508/4885CA1 2357/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.